Shao-xiong Wu
State Key Laboratory Of Oncology In South China, Guangdong Key Laboratory Of Nasopharyngeal Carcinoma Diagnosis And Therapy
Guangzhou, China
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Apatinib for recurrent/progressive glioblastoma multiforme: A salvage option.
Journal: Frontiers in pharmacology
Published: June 15, 2022
Potential Therapeutic Application of Local Anesthetics in Cancer Treatment.
Journal: Recent patents on anti-cancer drug discovery
Published: October 01, 2021
Induction chemotherapy with lobaplatin and fluorouracil versus cisplatin and fluorouracil followed by chemoradiotherapy in patients with stage III-IVB nasopharyngeal carcinoma: an open-label, non-inferiority, randomised, controlled, phase 3 trial.
Journal: The Lancet. Oncology
Published: October 02, 2020
Upfront Cranial Radiotherapy vs. EGFR Tyrosine Kinase Inhibitors Alone for the Treatment of Brain Metastases From Non-small-cell Lung Cancer: A Meta-Analysis of 1465 Patients.
Journal: Frontiers in oncology
Published: September 22, 2018
Low serum level of miR-485-3p predicts poor survival in patients with glioblastoma.
Journal: PloS one
Published: November 03, 2016
A prospective, randomized, multi-center trial to investigate Actovegin in prevention and treatment of acute oral mucositis caused by chemoradiotherapy for nasopharyngeal carcinoma.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: October 18, 2009
Outcome of fractionated stereotactic radiotherapy for 90 patients with locally persistent and recurrent nasopharyngeal carcinoma.
Journal: International journal of radiation oncology, biology, physics
Published: December 11, 2006
Showing 1-8 of 8
Last Updated: 09/26/2026